Simon Tchekmedyian

Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

F. Saad, D. M. Gleason, R. Murray et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +14

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations

Medicine, Oncology, Pharmacotherapy +17

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

John A. Glaspy, Ronald Bukowski, Douglas Steinberg et al. · Journal of Clinical Oncology · 1997 · 705 citations

Medicine, Hematology, Pharmacology +13

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

Matthew R. Smith, James A. Eastham, Donald M. Gleason et al. · The Journal of Urology · 2003 · 648 citations

Medicine, Oncology, Pharmacotherapy +14

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

David H. Henry, Naomi V. Dahl, Michael Auerbach et al. · The Oncologist · 2007 · 268 citations · Full text

Medicine, Hematology, Pharmacology +17